Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19

The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation

Center for Pain & Stress Research, a bio-electronic medical research company, announced that its Dolphin Vagal Stim device has received breakthrough approval from Health Canada as Canada’s first therapy for treating Covid-19.

There is one therapy quietly saving thousands of Covid lives, and it is approved by Health Canada for Covid-19 acute respiratory distress. It is called Dolphin Vagal Stimulation. The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation. The Vagus nerve is considered the "brakes" of our bodies, controlling 80% of our parasympathetic response, the company said in its release.

Dolphin Vagal Nerve Stimulator is now authorized by Health Canada for emergency use authorization for acute use at home or in a healthcare setting to treat adult patients with known or suspected Covid-19 who are experiencing an exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved pharmacologic therapies are not tolerated or provide insufficient symptom relief as assessed by their healthcare provide.

Company spokesperson Yulia Kramarenko states that "as North American Covid-19 related deaths reach more than 1.3 million casualties, knowledge of this effective, safe & approved Covid-19 therapy must be shared with both health carHe professionals and the public".